Anti-FITC MultiSort Kit

The Anti-FITC MultiSort Kit is a magnetic labeling system which allows the sorting of cells according to multiple surface markers. Cells are first stained with a fluorescein isothiocyanate (FITC)-conjugated primary antibody and subsequently magnetically labeled with Anti-FITC MultiSort MicroBeads. Following positive selection, the magnetic particles are removed from the cells by using the MultiSort Release Reagent. The cell population can then be magnetically labeled and sorted using a second marker of interest. This is achieved by labeling the cells directly or indirectly with MACS®</

... read more
qualityAssuranceSatisfaction
guaranteed
more »
Product data and images for Anti-FITC MultiSort Kit
Figure 1

Isolation of CD4+CD45RA+ T cells from PBMCs with CD4-FITC, Anti-FITC MultiSort Kit, and CD45RA MicroBeads.

Specifications for Anti-FITC MultiSort Kit
Overview

The Anti-FITC MultiSort Kit is a magnetic labeling system which allows the sorting of cells according to multiple surface markers. Cells are first stained with a fluorescein isothiocyanate (FITC)-conjugated primary antibody and subsequently magnetically labeled with Anti-FITC MultiSort MicroBeads. Following positive selection, the magnetic particles are removed from the cells by using the MultiSort Release Reagent. The cell population can then be magnetically labeled and sorted using a second marker of interest. This is achieved by labeling the cells directly or indirectly with MACS® MicroBeads.

Detailed product information
Detailed separation procedure

Cells are first stained with a fluorescein isothiocyanate (FITC)-conjugated primary antibody and subsequently magnetically labeled with Anti-FITC MultiSort MicroBeads. Following positive selection, the magnetic particles are removed from the cells by using the MultiSort Release Reagent. The cell population can then be magnetically labeled and sorted using a second marker of interest. This is achieved by labeling the cells directly or indirectly with MACS® MicroBeads.

Applications

The Anti-FITC MultiSort Kit has been used for the isolation of murine cytotoxic T cell subsets1,2 or αE+CD4+ and αE+CD4- T cell subsets from murine spleen and lymph nodes3. The kit has also been used for the isolation of CD4+CCR5+ cells from synovial fluid mononuclear cells of patients with rheumatoid arthritis4 and for the separation of CD3+CD56+ NKT cells, CD3+CD56- T cells and CD3-CD56+ NK cells from human liver5. Moreover, the kit has been used for the separation of human CD4+CD45RO+ T cells into CD25+ and CD25- subsets for further sorting according to CLA or CCR7 expression.6 Another application is the separation of murine GR-1+ cells from peripheral blood prior to MACS Separation into GR-1+CD18+ and GR-1+CD18- subsets.7

Columns

MS, LS, XS, or autoMACS® Columns.

Resources for Anti-FITC MultiSort Kit
Certificates

To access a Safety Data Sheet for a hazardous product or component in English or Swedish language, follow the link below and enter the catalog number of the product.

Please note, that the Safety Data Sheet has a cover sheet only in English language.

Should you wish a Safety Data Sheet (SDS) in other languages than English or Swedish, please contact Technical Support.

Get Safety Data Sheet

Citations for Anti-FITC MultiSort Kit
Publications
  1. Holtappels, R. et al. (2000) Enrichment of immediate-early 1 (m123/pp89) peptide-specific CD8 T cells in a pulmonary CD62L(lo) memory-effector cell pool during latent murine cytomegalovirus infection of the lungs. J. Virol. 24: 11495-11503
  2. Suzuki, N. et al. (1999) Selective accumulation of CCR5+ T lymphocytes into inflamed joints of rheumatoid arthritis. Int. Immunol. 11: 553-559
  3. Iellem, A. et al. (2003) Skin-versus gut-skewed homing receptor expression and intrinsic CCR4 expression on human peripheral blood CD4+CD25+ suppressor T cells. Eur. J. Immunol. 33: 1488-1496
  4. Flynn, S. et al. (1998) CD4 T cell cytokine differentiation: the B cell activation molecule, OX40 ligand, instructs CD4 T cells to express interleukin 4 and upregulates expression of the chemokine receptor, Blr-1. J. Exp. Med. 188: 297-304
  5. Weinmann, P. et al. (2003) A role for apoptosis in the control of neutrophil homeostasis in the circulation: insights from CD18-deficient mice. Blood 101: 739-746
  6. Lehmann, J. et al. (2002) Expression of the integrin alpha Ebeta 7 identifies unique subsets of CD25+ as well as CD25- regulatory T cells. Proc. Natl. Acad. Sci. U.S.A. 99: 13031-13036
  7. Doherty, D. G. et al. (1999) The human liver contains multiple populations of NK cells, T cells, and CD3+CD56+ natural T cells with distinct cytotoxic activities and Tʜ1, Tʜ2, and Tʜ0 cytokine secretion patterns. J Immunol 163: 2314-2321

You have previously chosen International as your location.
What do you want to do?